Abiomed traded at $278.18 this Thursday August 18th, decreasing $3.64 or 1.29 percent since the previous trading session. Looking back, over the last four weeks, Abiomed lost 3.28 percent. Over the last 12 months, its price fell by 16.55 percent. Looking ahead, we forecast Abiomed to be priced at 285.37 by the end of this quarter and at 262.06 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
278.18
Daily Change
-1.29%
Yearly
-16.55%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Terumo 4,627.00 12.00 0.26% 2.07%
Abiomed 278.18 -3.64 -1.29% -16.55%
Abbott 109.96 -0.59 -0.53% -12.95%
AtriCure 50.43 -0.12 -0.24% -30.55%
Avanos Medical Inc 27.13 -0.33 -1.20% -16.57%
Baxter International 61.05 -0.33 -0.54% -18.62%
Boston Scientific 42.63 0.20 0.47% -3.70%
Cooper Companies 326.97 -2.10 -0.64% -26.03%
Cardiovascular Systems 16.00 -0.19 -1.17% -55.78%
Dexcom 87.53 -0.61 -0.69% -30.74%
Edwards Lifesciences 99.51 -1.02 -1.01% -15.63%
Getinge 218.90 -0.70 -0.32% -39.80%
Globus Medical 66.22 -0.30 -0.45% -14.29%
Hologic 71.58 -0.31 -0.43% -6.50%
Integra LifeSciences 54.57 -0.31 -0.56% -22.96%
Inogen 31.60 0.60 1.94% -47.46%
Invacare 0.87 0.01 0.81% -89.03%
J&J 166.77 -0.81 -0.48% -6.61%
Masimo 159.93 -5.61 -3.39% -42.48%
Medtronic 95.24 0.33 0.35% -26.13%
Merit Medical Systems 61.05 -0.96 -1.55% -10.65%
NuVasive 50.83 0.39 0.77% -12.48%
Insulet 271.32 4.72 1.77% -7.97%
Sientra 0.91 -0.07 -7.01% -83.95%
Stryker 220.84 -0.59 -0.27% -16.75%
Teleflex 245.45 0.51 0.21% -34.69%
Tandem Diabetes Care 51.55 -1.26 -2.39% -53.65%
Zimmer Biomet Holdings Inc 114.52 -0.12 -0.10% -20.54%

Indexes Price Day Year
USND 12965 27.22 0.21% -10.84%
US2000 2001 13.41 0.68% -6.18%
US500 4252 9.70 0.23% -4.27%

Abiomed
ABIOMED, Inc. is a provider of medical devices, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to improve blood flow and/or performing the pumping function of the heart. Its products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. Its operating segment includes the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. Its existing products include Impella 2.5, Impella CP, Impella 5.0 and Impella LD. The Impella 2.5 device is a percutaneous micro heart pump with an integrated motor and sensors. The Impella CP device provides blood flow of approximately one liter more per minute than the Impella 2.5 device.